Glaukos (GKOS) Capital Expenditures (QoQ) (2014 - 2026)
Glaukos (GKOS) Capital Expenditures (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 316.10% |
| Dec 31, 2025 | -212.05% |
| Sep 30, 2025 | 38.68% |
| Jun 30, 2025 | -39.16% |
| Mar 31, 2025 | 179.17% |
| Dec 31, 2024 | -161.03% |
| Sep 30, 2024 | 335.39% |
| Jun 30, 2024 | -176.90% |
| Mar 31, 2024 | 218.63% |
| Dec 31, 2023 | -1,643.80% |
| Sep 30, 2023 | -81.64% |
| Jun 30, 2023 | -72.78% |
| Mar 31, 2023 | 111.15% |
| Dec 31, 2022 | -215.92% |
| Sep 30, 2022 | 505.69% |
| Jun 30, 2022 | 1,325.35% |
| Mar 31, 2022 | -99.55% |
| Dec 31, 2021 | 267.18% |
| Sep 30, 2021 | -200.26% |
| Jun 30, 2021 | 98,620.69% |